{"schema_version":"1","generated_at":"2026-10-29T20:06:02.773Z","data_as_of":null,"url":"https://www.findmykol.com/kol/kira-gritsman","json_url":"https://www.findmykol.com/kol/kira-gritsman/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"kira-gritsman","name":"Kira Gritsman","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"city":"Boston","state":"MA","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1174598148","orcid":"0000-0002-1367-1167","openalex":"A5058562431"},"summary":"Kira Gritsman is an Oncology physician. OpenAlex indexes 259 publications with 3,702 citations (h-index 23).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":259,"cited_by_count":3702,"h_index":23,"latest_activity_year":2026,"source":"works"},"payments":{"company_count":2,"program_years":{"first":2021,"last":null},"rows_total":2,"shown":2,"withheld":0,"rows":[{"payer":"Medtronic, Inc.","program_year":2025,"amount_usd":73.75,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1174598148"},{"payer":"Amgen Inc.","program_year":2022,"amount_usd":30.47,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1174598148"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1174598148","source":"payments"},"funding":{"award_count":1,"fiscal_years":{"first":2010,"last":2013},"rows_total":4,"shown":3,"withheld":1,"matched_by":"principal investigator name at an organization in the practice state","rows":[{"project":"K08CA149208","title":"The p110 alpha and delta isoforms of PI3 kinase in hematopoiesis and leukemia","fiscal_year":2013,"amount_usd":"177880","organization":"DANA-FARBER CANCER INST","source_url":"https://reporter.nih.gov/quickSearch/K08CA149208"},{"project":"K08CA149208","title":"The p110 alpha and delta isoforms of PI3 kinase in hematopoiesis and leukemia","fiscal_year":2012,"amount_usd":"177880","organization":"DANA-FARBER CANCER INST","source_url":"https://reporter.nih.gov/quickSearch/K08CA149208"},{"project":"K08CA149208","title":"The p110 alpha and delta isoforms of PI3 kinase in hematopoiesis and leukemia","fiscal_year":2011,"amount_usd":"177560","organization":"DANA-FARBER CANCER INST","source_url":"https://reporter.nih.gov/quickSearch/K08CA149208"}],"source":"grants"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"A STAT3 degrader demonstrates efficacy in venetoclax resistant acute myeloid leukemia","year":2026,"journal":"Leukemia","source_url":"https://doi.org/10.1038/s41375-026-02883-9","status":"verified"},{"title":"Efficacy of a novel BCL-xL degrader, DT2216, in preclinical models of <i>JAK2</i>-mutated post-MPN AML","year":2025,"journal":"Blood","source_url":"https://doi.org/10.1182/blood.2024027117","status":"verified"},{"title":"Targeting the CD74 signaling axis suppresses inflammation and rescues defective hematopoiesis in <i>RUNX1</i> -familial platelet disorder","year":2025,"journal":"Science Translational Medicine","source_url":"https://doi.org/10.1126/scitranslmed.adn9832","status":"verified"},{"title":"Venetoclax plus daunorubicin and cytarabine for newly diagnosed acute myeloid leukemia: results of a phase 1b study","year":2025,"journal":"Blood","source_url":"https://doi.org/10.1182/blood.2024026700","status":"verified"},{"title":"Small-molecule OPA1 inhibitors reverse mitochondrial adaptations to overcome therapy resistance in acute myeloid leukemia","year":2025,"journal":"Science Advances","source_url":"https://doi.org/10.1126/sciadv.adx8662","status":"verified"}],"source":"works"},"contact":{"address_1":"55 FRUIT STREET","address_2":"YAW 7604","city":"Boston","state":"MA","zip":"02114","phone":"617-724-2241","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1174598148","source":"identity"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"funding":1,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2025-09-11","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}